The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

Some 20 travel staff at the FDA, who made arrangements for the regulator’s inspectors, will be getting their jobs back, as ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

Per the Post, which first reported the story, “‘All new vaccines will undergo safety testing in placebo-controlled trials ...

A major change in the way HHS plans to evaluate vaccine safety is raising fears that approvals will become unnecessarily ...

The U.S. Health and Human Services Department says it will require placebo testing of "all new vaccines," raising questions ...

Lavina Talukdar; Senior Vice President & Head of Investor Relations; Moderna Inc. Stephane Bancel; Chief Executive Officer, Director; Moderna Inc. James Mock; Chief ...